KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) EBT (2017 - 2026)

Arcosa's EBT history spans 10 years, with the latest figure at $24.6 million for Q1 2026.

  • On a quarterly basis, EBT rose 70.83% to $24.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $236.7 million, a 143.77% increase, with the full-year FY2025 number at $241.3 million, up 85.62% from a year prior.
  • EBT hit $24.6 million in Q1 2026 for Arcosa, down from $55.2 million in the prior quarter.
  • Over the last five years, EBT for ACA hit a ceiling of $199.9 million in Q4 2022 and a floor of $10.4 million in Q4 2024.
  • Historically, EBT has averaged $52.5 million across 5 years, with a median of $46.5 million in 2023.
  • Biggest five-year swings in EBT: surged 2337.8% in 2022 and later plummeted 81.74% in 2023.
  • Tracing ACA's EBT over 5 years: stood at $199.9 million in 2022, then plummeted by 81.74% to $36.5 million in 2023, then crashed by 71.51% to $10.4 million in 2024, then surged by 430.77% to $55.2 million in 2025, then crashed by 55.43% to $24.6 million in 2026.
  • Business Quant data shows EBT for ACA at $24.6 million in Q1 2026, $55.2 million in Q4 2025, and $87.1 million in Q3 2025.